An outcome measure of functionality and pain in patients with low back disorder: A validation study of the Iranian version of Core Outcome Measures Index

腰背部疾病患者功能和疼痛的结局指标:核心结局指标指数伊朗版的验证研究

阅读:2

Abstract

BACKGROUND: Lumbar Disc Herniation (LDH) and Lumbar Spinal Stenosis (LSS) are the most common diagnoses of low back and leg pain symptoms. This study aimed to cross-culturally translate, and validate the Core Outcome Measures Index (COMI) in Iran. METHODS: The translation and cross-cultural adaptation of the original questionnaire were performed in accordance with published guidelines. A total of 121 patients with LDH or LSS were asked to respond to the questionnaire at two points in time: Pre and postoperative assessments (6 months follow-up). The Oswestry Disability Index (ODI) also was completed. To test the reliability, the internal consistency was assessed by Cronbach's alpha coefficient, and validity was assessed using convergent validity. Responsiveness to change also was assessed for comparing patients' pre and postoperative scores. RESULTS: The Cronbach's alpha coefficients for the COMI at pre and postoperative assessments ranged from 0.79 to 0.82, indicating a good internal consistency. The change in the ODI after surgery was strongly correlated with change in the COMI, lending support to its good convergent validity (r = 0.79 for LDH and r = 0.77 for LSS; P < 0.001). In addition, the correlation of each item with its hypothesized subscale of the COMI showed satisfactory results suggesting, that the items had a substantial association with the subscale, representing the concept. Further analysis also indicated that the questionnaire was responsive to change (P < 0.0001). CONCLUSION: The Iranian version of COMI performed well, and the findings suggest that it is a reliable and valid measure of back pain treatment evaluation among LDH and lumbar canal stenosis patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。